{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T05:07:21Z","timestamp":1739596041868,"version":"3.37.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Legend Biotech USA Inc"},{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs, LLC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00520-025-09195-1","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T22:28:17Z","timestamp":1738362497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient and caregiver perspectives on\u00a0treatment decision-making for stem cell transplantation in multiple myeloma"],"prefix":"10.1007","volume":"33","author":[{"given":"Doris K.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Bixby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Fixler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Shea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Brittle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hsuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Brunisholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhai Stephen","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"9195_CR1","first-page":"44","volume":"9","author":"R Al Hamed","year":"2019","unstructured":"Al Hamed R, Bazarbachi AH, Malard F, Harousseau JL, Mohty M (2019) Current status of autologous stem cell transplantation for multiple myeloma Blood. Cancer J 9:44","journal-title":"Cancer J"},{"key":"9195_CR2","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","volume":"376","author":"M Attal","year":"2017","unstructured":"Attal M, Lauwers-Cances V, Hulin C, Leleu X, Caillot D, Escoffre M, Arnulf B, Macro M, Belhadj K, Garderet L, Roussel M, Payen C, Mathiot C, Fermand JP, Meuleman N, Rollet S, Maglio ME, Zeytoonjian AA, Weller EA, Munshi N, Anderson KC, Richardson PG, Facon T, Avet-Loiseau H, Harousseau JL, Moreau P (2017) Lenalidomide. bortezomib, and dexamethasone with transplantation for myeloma. N Engl J Med 376:1311\u20131320","journal-title":"N Engl J Med"},{"key":"9195_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa2204925","volume":"387","author":"PG Richardson","year":"2022","unstructured":"Richardson PG, Jacobus SJ, Weller EA, Hassoun H, Lonial S, Raje NS, Medvedova E, McCarthy PL, Libby EN, Voorhees PM, Orlowski RZ, Anderson LD Jr, Zonder JA, Milner CP, Gasparetto C, Agha ME, Khan AM, Hurd DD, Gowin K, Kamble RT, Jagannath S, Nathwani N, Alsina M, Cornell RF, Hashmi H, Campagnaro EL, Andreescu AC, Gentile T, Liedtke M, Godby KN, Cohen AD, Openshaw TH, Pasquini MC, Giralt SA, Kaufman JL, Yee AJ, Scott E, Torka P, Foley A, Fulciniti M, Hebert K, Samur MK, Masone K, Maglio ME, Zeytoonjian AA, Nadeem O, Schlossman RL, Laubach JP, Paba-Prada C, Ghobrial IM, Perrot A, Moreau P, Avet-Loiseau H, Attal M, Anderson KC, Munshi NC (2022) Triplet therapy, transplantation, and maintenance until progression in myeloma. N Engl J Med 387:132\u2013147","journal-title":"N Engl J Med"},{"key":"9195_CR4","doi-asserted-by":"crossref","unstructured":"Voorhees PM, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, Chari A, Silbermann R, Costa LJ, Anderson LD, Jr., Nathwani N, Shah N, Efebera YA, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Orlowski RZ, Shain KH, Cowan AJ, Murphy S, Lutska Y, Pei H, Ukropec J, Vermeulen J, de Boer C, Hoehn D, Lin TS, Richardson PG (2020) Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial Blood 136: 936\u2013945","DOI":"10.1182\/blood.2020005288"},{"key":"9195_CR5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1182\/blood-2014-03-544759","volume":"124","author":"MA Gertz","year":"2014","unstructured":"Gertz MA, Dingli D (2014) How we manage autologous stem cell transplantation for patients with multiple myeloma. Blood 124:882\u2013890","journal-title":"Blood"},{"key":"9195_CR6","doi-asserted-by":"crossref","unstructured":"Bashir Q, Braunstein M, Buck T, Chmielewski C, Hartmann B, Janakiram M, McMahon MA, Romundstad L, Steele L, Usmani S, Zwibel K, Kharfan-Dabaja MA (2023) Overcoming barriers to autologous stem cell transplantation in multiple myeloma: recommendations from a multidisciplinary roundtable discussion Transplant Cell Ther","DOI":"10.1016\/j.jtct.2023.08.028"},{"key":"9195_CR7","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1016\/j.clml.2019.05.003","volume":"19","author":"MA Fiala","year":"2019","unstructured":"Fiala MA, Vij R, Wildes TM (2019) A mixed-methods study of stem cell transplantation utilization for newly diagnosed multiple myeloma. Clin Lymphoma Myeloma Leuk 19:e521\u2013e525","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"9195_CR8","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.bbmt.2015.05.013","volume":"21","author":"GL Shah","year":"2015","unstructured":"Shah GL, Winn AN, Lin PJ, Klein A, Sprague KA, Smith HP, Buchsbaum R, Cohen JT, Miller KB, Comenzo R, Parsons SK (2015) Cost-effectiveness of autologous hematopoietic stem cell transplantation for elderly patients with multiple myeloma using the surveillance, epidemiology, and end results-Medicare Database. Biol Blood Marrow Transplant 21:1823\u20131829","journal-title":"Biol Blood Marrow Transplant"},{"key":"9195_CR9","doi-asserted-by":"publisher","first-page":"e714","DOI":"10.1016\/j.clml.2021.05.002","volume":"21","author":"MS Ebraheem","year":"2021","unstructured":"Ebraheem MS, Seow H, Balitsky AK, Pond GR, Wildes TM, Sivapathasundaram B, Sussman J, Mian H (2021) Trajectory of symptoms in patients undergoing autologous stem cell transplant for multiple myeloma: a population-based cohort study of patient-reported outcomes. Clin Lymphoma Myeloma Leuk 21:e714\u2013e721","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"9195_CR10","doi-asserted-by":"publisher","first-page":"237437352312027","DOI":"10.1177\/23743735231202733","volume":"10","author":"DK Hansen","year":"2023","unstructured":"Hansen DK, Bixby T, Fixler K, Shea L, Brittle C, Brunisholz K, Liu YH, Huo JS (2023) Experience of autologous stem cell transplant in multiple myeloma: the patient and caregiver perspective. J Patient Exp 10:23743735231202732","journal-title":"J Patient Exp"},{"key":"9195_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1200\/JCO.2017.74.2270","volume":"36","author":"N Sharafeldin","year":"2018","unstructured":"Sharafeldin N, Bosworth A, Patel SK, Chen Y, Morse E, Mather M, Sun C, Francisco L, Forman SJ, Wong FL, Bhatia S (2018) Cognitive functioning after hematopoietic cell transplantation for hematologic malignancy: results from a prospective longitudinal study. J Clin Oncol 36:463\u2013475","journal-title":"J Clin Oncol"},{"key":"9195_CR12","unstructured":"H. Lee Moffitt Cancer Center & Research Institute Blood and Marrow Transplantation and Cellular Immunotherapy Program. Autologous Transplantation Patient and Caregiver Guide. 2013. . In: Editor (ed)^(eds) Book H. Lee Moffitt Cancer Center & Research Institute Blood and Marrow Transplantation and Cellular Immunotherapy Program. Autologous Transplantation Patient and Caregiver Guide. 2013, City."},{"key":"9195_CR13","unstructured":"Health Tree Foundation. The Autologous Stem Cell Transplant Guide. 2023."},{"key":"9195_CR14","doi-asserted-by":"crossref","unstructured":"Cytryn R, Bickell N, Yagnik R, Jagannath S, Lin JJ (2023) What affects treatment underuse in multiple myeloma in the United States: a qualitative study Cancers (Basel) 15","DOI":"10.3390\/cancers15082369"},{"key":"9195_CR15","doi-asserted-by":"publisher","first-page":"e18790","DOI":"10.1200\/JCO.2023.41.16_suppl.e18790","volume":"41","author":"DK Hansen","year":"2023","unstructured":"Hansen DK, Bixby T, Fixler K, Shea L, Brittle C, Brunisholz K, Liu Y-H, Huo J (2023) Experience of a stem cell transplant in multiple myeloma: the patient and care partner perspective. J Clin Oncol 41:e18790\u2013e18790","journal-title":"J Clin Oncol"},{"key":"9195_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2147\/PPA.S241340","volume":"14","author":"WY Jen","year":"2020","unstructured":"Jen WY, Yoong J, Liu X, Tan MSY, Chng WJ, Chee YL (2020) Qualitative study of factors affecting patient, caregiver and physician preferences for treatment of myeloma and indolent lymphoma patient. Prefer Adherence 14:301\u2013308","journal-title":"Prefer Adherence"},{"key":"9195_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3322\/caac.21245","volume":"64","author":"HL Kane","year":"2014","unstructured":"Kane HL, Halpern MT, Squiers LB, Treiman KA, McCormack LA (2014) Implementing and evaluating shared decision making in oncology practice. CA Cancer J Clin 64:377\u2013388","journal-title":"CA Cancer J Clin"},{"key":"9195_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1186\/s12885-021-08527-8","volume":"21","author":"C Pritlove","year":"2021","unstructured":"Pritlove C, Jassi M, Burns B, McCurdy A (2021) The work of managing multiple myeloma and its implications for treatment-related decision making: a qualitative study of patient and caregiver experiences. BMC Cancer 21:793","journal-title":"BMC Cancer"},{"key":"9195_CR19","doi-asserted-by":"publisher","first-page":"8040","DOI":"10.1002\/cam4.4322","volume":"10","author":"RL Whitney","year":"2021","unstructured":"Whitney RL, White AEC, Rosenberg AS, Kravitz RL, Kim KK (2021) Trust and shared decision-making among individuals with multiple myeloma: a qualitative study. Cancer Med 10:8040\u20138057","journal-title":"Cancer Med"},{"key":"9195_CR20","doi-asserted-by":"publisher","first-page":"e050816","DOI":"10.1136\/bmjopen-2021-050816","volume":"12","author":"D McCaughan","year":"2022","unstructured":"McCaughan D, Roman E, Smith A, Patmore R, Howell D (2022) Treatment decision making (TDM): a qualitative study exploring the perspectives of patients with chronic haematological cancers. BMJ Open 12:e050816","journal-title":"BMJ Open"},{"key":"9195_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40744-021-00289-w","volume":"8","author":"SD Chakravarty","year":"2021","unstructured":"Chakravarty SD, Abell J, Leone-Perkins M, Orbai AM (2021) A novel qualitative study assessing patient-reported outcome measures among people living with psoriatic arthritis or ankylosing spondylitis. Rheumatol Ther 8:609\u2013620","journal-title":"Rheumatol Ther"},{"key":"9195_CR22","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1111\/hex.13554","volume":"25","author":"L Shea","year":"2022","unstructured":"Shea L, Pesa J, Geonnotti G, Powell V, Kahn C, Peters W (2022) Improving diversity in study participation: patient perspectives on barriers, racial differences and the role of communities. Health Expect 25:1979\u20131987","journal-title":"Health Expect"},{"key":"9195_CR23","doi-asserted-by":"crossref","unstructured":"Tong A, Sainsbury P, Craig J (2007) Consolidated Criteria for Reporting Qualitative Research (COREQ): a 32-item checklist for interviews and focus groups International Journal for Quality in Health Care 19: 349\u2013357","DOI":"10.1093\/intqhc\/mzm042"},{"key":"9195_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1200\/JOP.19.00335","volume":"16","author":"RD Parrondo","year":"2020","unstructured":"Parrondo RD, Ailawadhi S, Sher T, Chanan-Khan AA, Roy V (2020) Autologous stem-cell transplantation for multiple myeloma in the era of novel therapies. JCO Oncol Pract 16:56\u201366","journal-title":"JCO Oncol Pract"},{"key":"9195_CR25","unstructured":"The Leukemia & Lymphoma Society. Blood and Marrow Stem Cell Transplantation. 2023."}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09195-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09195-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09195-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T05:41:55Z","timestamp":1739511715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09195-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["9195"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09195-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"21 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DKH has consulted with BMS, Karyopharm, Janssen, Kite Pharma, AstraZeneca, and Pfizer; received research funding from BMS, Kite Pharma, Karyopharm, and the Pentecost Family Myeloma Research Center.TB, KF, LS, KB, YL, and JSH are employees of Janssen Scientific Affairs, LLC, and hold Johnson & Johnson stock. CB is an employee of CorEvitas, which provided analytical services funded by Janssen Pharmaceuticals. JM reports nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"134"}}